Efficacy and Safety of a Combined Topical Formula Versus Placebo in Patients With Melasma | MicrobiomeTrials← Back to trialsNCT07727954
Efficacy and Safety of a Combined Topical Formula Versus Placebo in Patients With Melasma
CompletedNAINTERVENTIONAL
Trial Details
Start: 2026-06-12Est. Completion: 2026-07-10
Enrollment target: 40 participants Locations- The Skin Place, Tijuana, Estado de Baja California, Mexico
Other microbiome trials you might be interested in
Skin AgingHyperpigmentation
This study evaluated whether a chemical skin biostimulator containing ammonium trichloroacetate, homocysteic acid, phyti…
Sosnowiec, PolandCompleted Apr 1, 2026
Melasma (Facial Melasma)
Melasma is a common skin condition characterized by brown or gray patches on sun-exposed areas of the face. Although sev…
Tanta, EgyptCompleted Jun 30, 2027